Ambu tops DKK 2bn in revenue and meets its strategic targets one year ahead of schedule. Organic growth of 9% was achieved in 2015/16, EBIT increased 50% to DKK 356m, and the EBIT margin landed at 17.1%. For 2016/17, the outlook is of organic growth of approx. 8-10%, an EBIT margin of approx. 18% and free cash flows of approx. DKK 175m.GlobeNewswire
Last updated on: 08/11/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.